C-DIM12

C-DIM12 is an activator of Dopamine Receptors and NF-kB used in studies of NF-kB Signaling and Immune Signaling and related signaling programs. It is especially relevant in apoptosis, cancer, and immunology models, where defined compound exposure can be linked to inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses.

By activating Dopamine Receptors and NF-kB, C-DIM12 can be used to examine inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Dopamine Receptors and NF-kB
• Pathway perturbation studies connected to NF-kB Signaling and Immune Signaling and related signaling programs
• Gain-of-function pathway-activation studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, C-DIM12 is appropriate when a defined chemical perturbant is needed to connect Dopamine Receptors and NF-kB with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.